Cantitate/Preț
Produs

Lipoprotein(a): Contemporary Cardiology

Editat de Karam Kostner, Gerhard M. Kostner, Peter P. Toth
en Limba Engleză Paperback – 5 mar 2024
Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 
 This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies.  Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 100196 lei  38-44 zile
  Springer International Publishing – 5 mar 2024 100196 lei  38-44 zile
Hardback (1) 142434 lei  38-44 zile
  Springer International Publishing – 4 mar 2023 142434 lei  38-44 zile

Din seria Contemporary Cardiology

Preț: 100196 lei

Preț vechi: 105469 lei
-5% Nou

Puncte Express: 1503

Preț estimativ în valută:
19175 19918$ 15928£

Carte tipărită la comandă

Livrare economică 29 ianuarie-04 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031245770
ISBN-10: 3031245776
Pagini: 443
Ilustrații: XVII, 443 p. 92 illus., 76 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer International Publishing
Colecția Humana
Seria Contemporary Cardiology

Locul publicării:Cham, Switzerland

Cuprins

60 years of Lp(a) research-From Ouchterlonys double diffusion to a significant risk factor for CHD.- Lp(a) structure and composition.- Genetics of Lipoprotein(a).- Lp(a) metabolism.- Contemporary aspects of Lp(a) metabolism and therapies based on tracer kinetic methods.- Role of Proprotein Convertase Subtilisin Kexin type 9 in Lipoprotein(a) Metabolism.- The Role of Cell Surface Receptors in Lp(a) Metabolism.- Physiological Roles And Functions Of Lipoprotein(a).- The role of Lp(a) in Atherosclerosis: An overview.- Role of macrophages in Lp(a) pathophysiology.- Thrombosis, Inflammation and Lipoprotein(a): Clinical Implications .- The role of the kidney in Lp(a) physiology and pathophysiology.- Lp(a) as a cardiovascular risk factor.- Lp(a) and aortic valve stenosis, stroke, and other non-coronary cardiovascular diseases.- Lp(a) in cardiovascular disease: Evidence from Large Epidemiological Studies.- Lipoprotein(A) And Immunity.- When to measure Lp(a) .- Measurement of Lipoprotein (a) in the Clinical Laboratory.- Standardization of analytical methods for the measurement of Lipoprotein(a): bridging  past and future initiatives.- Establishing an SI-traceable Reference Measurement System for Lp(a), based on Quantitative Protein Mass Spectrometry and Molar Units.- Compounds that impact Lp(a) concentrations.- Antisense oligonucleotide therapy to treat elevated lipoprotein(a).- Lipoprotein apheresis for reduction of Lipoprotein(a).- Elevated Lp(a) - Why Should I Test For It, If I Cannot Treat It? A Patient’s Perspective .- Burning unanswered questions Therapy.


Notă biografică

Karam Kostner, MD, Ph.D., FRACP,  FCSANZ
Associate Professor of Medicine
University of Queensland and Mater Hospital
Brisbane, Australia


Gerhard M. Kostner, Ph.D.
Emeritus Professor of Biochemistry and Molecular Biology
Medical University of Graz, Austria
Graz, Austria

Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC
Adjunct Professor of Medicine
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, Maryland  USA

Textul de pe ultima copertă

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 
 
This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. 
 
Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Caracteristici

Provides comprehensive coverage of lipoprotein(a) and its role in the development of cardiovascular disease Highlights current and future therapies for combating high levels of lipoprotein(a) Brings awareness to an often overlooked risk factor of heart attacks and other serious cardiovascular events